Sangrix annual return on equity
2018
2019
2020
2021
2022
2023
2024
2025
2026
Sangrix Return on Equity (ROE) Growth & History (SGRX)
Sangrix's return on equity was −300.28% for fiscal 2026.
View full Sangrix company overviewSangrix annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-06-30 | −300.28% | −143.17 pp |
| 2025 | 2025-06-30 | −157.11% | +136.95 pp |
| 2024 | 2024-06-30 | −294.06% | −168.42 pp |
| 2023 | 2023-06-30 | −125.64% | −146.25 pp |
| 2022 | 2022-06-30 | 20.61% | +463.75 pp |
| 2021 | 2021-06-30 | −443.14% | −422.96 pp |
| 2020 | 2020-06-30 | −20.18% | −42.81 pp |
| 2019 | 2019-06-30 | 22.63% | −8.55 pp |
| 2018 | 2018-06-30 | 31.19% | — |
Sangrix return on equity trends
Over the last five fiscal years, Sangrix's return on equity increased from −443.14% to −300.28%, a change of +142.85 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sangrix source filings ↗